The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Smith Margaret Ekins | Chief Commercial Officer | Grant(A) | 1.0M | — | $0 |
| Jul 1, 2026 | Casale Donn | President | Grant(A) | 898K | — | $0 |
| Jun 24, 2026 | Ra Capital Management, L.P. | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Dadoo Rajeev | Director | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Shah Pratik | Director | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Kelly Michael | Director | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Islam Saqib | Director | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Thompson Peter A. | Director | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Saunders Brent L | Director | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Schneider Phillip M | Director | Grant(A) | 30K | — | $0 |
| Jun 24, 2026 | Shawver Laura | Director | Grant(A) | 30K | — | $0 |
| Jun 12, 2026 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 25K | $1.50 | $38K |
| Jun 12, 2026 | Karas Eric | Chief Commercial Officer | Sell(S) | 25K | $10.00 | $250K |
| Jun 12, 2026 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 25K | — | $0 |
| Jun 12, 2026 | Fitzpatrick Alexander A | Chief Legal Officer | Sell(S) | 3K | $10.00 | $34K |
| Jan 2, 2026 | Lowenthal Richard E | PRESIDENT AND CEO, Director, 10% Owner | Grant(A) | 240K | — | $0 |
| Jan 2, 2026 | Lowenthal Richard E | PRESIDENT AND CEO, Director, 10% Owner | Grant(A) | 875K | — | $0 |
| Jan 2, 2026 | Dorsey Brian | Chief Operating Officer | Grant(A) | 240K | — | $0 |
| Jan 2, 2026 | Fitzpatrick Alexander A | Chief Legal Officer | Grant(A) | 240K | — | $0 |
| Jan 2, 2026 | Scott Kathleen D. | Chief Financial Officer | Grant(A) | 240K | — | $0 |
| Jan 2, 2026 | Chakma Justin | Chief Business Officer | Grant(A) | 240K | — | $0 |
| Jan 2, 2026 | Karas Eric | Chief Commercial Officer | Grant(A) | 240K | — | $0 |
| Jan 2, 2026 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Grant(A) | 240K | — | $0 |
| Jan 2, 2026 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Grant(A) | 875K | — | $0 |
| Nov 13, 2025 | Dorsey Brian | Chief Operating Officer | Option exercise(M) | 22K | $0.64 | $14K |
| Nov 13, 2025 | Dorsey Brian | Chief Operating Officer | Sell(S) | 22K | $8.71 | $190K |
| Nov 13, 2025 | Dorsey Brian | Chief Operating Officer | Option exercise(M) | 22K | — | $0 |
| Nov 12, 2025 | Shah Pratik | Director | Gift(G) | 100K | — | $0 |
| Nov 12, 2025 | Shah Pratik | Director | Gift(G) | 250K | — | $0 |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell(S) | 136K | $8.86 | $1.2M |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell(S) | 30K | $8.91 | $267K |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Option exercise(M) | 30K | $0.84 | $25K |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Option exercise(M) | 30K | — | $0 |
| Aug 21, 2025 | Scott Kathleen D. | Chief Financial Officer | Option exercise(M) | 13K | $1.50 | $19K |
| Aug 21, 2025 | Scott Kathleen D. | Chief Financial Officer | Sell(S) | 13K | $15.00 | $188K |
| Aug 21, 2025 | Scott Kathleen D. | Chief Financial Officer | Option exercise(M) | 13K | — | $0 |
| Aug 21, 2025 | Lowenthal Richard E | PRESIDENT AND CEO, Director, 10% Owner | Sell(S) | 50K | $14.49 | $725K |
| Aug 20, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Sell(S) | 38K | $14.09 | $531K |
| Aug 19, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Sell(S) | 12K | $14.03 | $173K |
| Jul 1, 2025 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 15K | $1.50 | $23K |
| Jul 1, 2025 | Karas Eric | Chief Commercial Officer | Sell(S) | 15K | $16.99 | $255K |
| Jul 1, 2025 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 15K | — | $0 |
| Jun 27, 2025 | Flynn James E | 10% Owner | Sell(S) | 370K | $18.46 | $6.8M |
| Jun 27, 2025 | Flynn James E | 10% Owner | Sell(S) | 370K | $18.46 | $6.8M |
| Jun 25, 2025 | Dadoo Rajeev | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Shawver Laura | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Schneider Phillip M | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Saunders Brent L | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Islam Saqib | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Shah Pratik | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Thompson Peter A. | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Kelly Michael | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2025 | Kolchinsky Peter | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Karas Eric | Chief Commercial Officer | Sell(S) | 15K | $16.00 | $240K |
| Jun 18, 2025 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 15K | $1.50 | $23K |
| Jun 18, 2025 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 15K | — | $0 |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | Option exercise(M) | 50K | $1.50 | $75K |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | Sell(S) | 50K | $14.10 | $705K |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | Option exercise(M) | 50K | — | $0 |
| May 20, 2025 | Saunders Brent L | Director | Option exercise(M) | 120K | $1.01 | $121K |
| May 20, 2025 | Saunders Brent L | Director | Sell(S) | 120K | $14.25 | $1.7M |
| May 20, 2025 | Saunders Brent L | Director | Option exercise(M) | 120K | — | $0 |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | Option exercise(M) | 100K | $5.58 | $558K |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | Sell(S) | 103K | $14.10 | $1.5M |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | Option exercise(M) | 100K | — | $0 |
| Apr 7, 2025 | Shawver Laura | Director | Option exercise(M) | 23K | $4.85 | $109K |
| Apr 7, 2025 | Shawver Laura | Director | Option exercise(M) | 27K | $4.85 | $133K |
| Apr 7, 2025 | Shawver Laura | Director | Sell(S) | 50K | $12.30 | $615K |
| Apr 7, 2025 | Shawver Laura | Director | Option exercise(M) | 23K | — | $0 |
| Apr 7, 2025 | Shawver Laura | Director | Option exercise(M) | 27K | — | $0 |
| Mar 20, 2025 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 10K | $1.50 | $15K |
| Mar 20, 2025 | Karas Eric | Chief Commercial Officer | Sell(S) | 10K | $14.00 | $140K |
| Mar 20, 2025 | Karas Eric | Chief Commercial Officer | Option exercise(M) | 10K | — | $0 |
| Mar 6, 2025 | Shawver Laura | Director | Sell(S) | 50K | $11.21 | $556K |
| Mar 6, 2025 | Shawver Laura | Director | Option exercise(M) | 50K | $4.85 | $241K |
| Mar 6, 2025 | Shawver Laura | Director | Option exercise(M) | 50K | — | $0 |
| Mar 5, 2025 | Shawver Laura | Director | Option exercise(M) | 400 | $4.85 | $2K |
| Mar 5, 2025 | Shawver Laura | Director | Sell(S) | 400 | $11.00 | $4K |
| Mar 5, 2025 | Shawver Laura | Director | Option exercise(M) | 400 | — | $0 |
| Feb 3, 2025 | Shawver Laura | Director | Option exercise(M) | 41K | $4.85 | $199K |
| Feb 3, 2025 | Shawver Laura | Director | Sell(S) | 50K | $12.31 | $616K |
| Feb 3, 2025 | Shawver Laura | Director | Option exercise(M) | 9K | $3.15 | $29K |
| Feb 3, 2025 | Shawver Laura | Director | Option exercise(M) | 41K | — | $0 |
| Feb 3, 2025 | Shawver Laura | Director | Option exercise(M) | 9K | — | $0 |
| Jan 6, 2025 | Shawver Laura | Director | Option exercise(M) | 50K | $3.15 | $158K |
| Jan 6, 2025 | Shawver Laura | Director | Sell(S) | 50K | $11.10 | $555K |
| Jan 6, 2025 | Shawver Laura | Director | Option exercise(M) | 50K | — | $0 |
| Jan 2, 2025 | Karas Eric | Chief Commercial Officer | Grant(A) | 152K | — | $0 |
| Jan 2, 2025 | Scott Kathleen D. | Chief Financial Officer | Grant(A) | 177K | — | $0 |
| Jan 2, 2025 | Chakma Justin | Chief Business Officer | Grant(A) | 274K | — | $0 |
| Jan 2, 2025 | Dorsey Brian | Chief Operating Officer | Grant(A) | 262K | — | $0 |
| Jan 2, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | Grant(A) | 152K | — | $0 |
| Jan 2, 2025 | Lowenthal Richard E | PRESIDENT AND CEO, Director, 10% Owner | Grant(A) | 262K | — | $0 |
| Jan 2, 2025 | Lowenthal Richard E | PRESIDENT AND CEO, Director, 10% Owner | Grant(A) | 768K | — | $0 |
| Jan 2, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Grant(A) | 262K | — | $0 |
| Jan 2, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Grant(A) | 768K | — | $0 |
| Dec 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO, Director, 10% Owner | Sell(S) | 50K | $11.67 | $584K |
| Dec 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO, Director, 10% Owner | Sell(S) | 50K | $11.67 | $584K |
| Dec 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Sell(S) | 50K | $11.67 | $584K |
| Dec 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER, 10% Owner | Sell(S) | 50K | $11.67 | $584K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-03. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SPRY